Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies. (Record no. 24553763)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02593 a2200793 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517013147.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201605s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1569-8041 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1093/annonc/mdv026 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Wong, A L |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20160519 |
| 245 00 - TITLE STATEMENT | |
| Title | Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of oncology : official journal of the European Society for Medical Oncology |
| Date of publication, distribution, etc. | May 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 998-1005 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Asia |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers, Tumor |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biotransformation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ErbB Receptors |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Half-Life |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Neoplasms |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Maximum Tolerated Dose |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Metabolic Clearance Rate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Targeted Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phosphorylation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | STAT3 Transcription Factor |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Signal Transduction |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Soo, R A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tan, D S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lee, S C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lim, J S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marban, P C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kong, L R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lee, Y J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, L Z |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thuya, W L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Soong, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yee, M Q |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chin, T M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cordero, M T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Asuncion, B R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pang, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pervaiz, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hirpara, J L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sinha, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xu, W W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yuasa, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsunoda, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Motoyama, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yamauchi, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Goh, B C |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of oncology : official journal of the European Society for Medical Oncology |
| Related parts | vol. 26 |
| -- | no. 5 |
| -- | p. 998-1005 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1093/annonc/mdv026">https://doi.org/10.1093/annonc/mdv026</a> |
| Public note | Available from publisher's website |
No items available.